Skip to main content
. 2018 Jul 20;9(56):30919–30935. doi: 10.18632/oncotarget.25778

Figure 6. Modulation of cytokine profiles in an in vitro model of intestinal inflammation by metabolites from SHIME reactors treated with the probiotic with digestive enzymes supplement.

Figure 6

Samples of SHIME suspensions were taken from reactors with curative (CUR) and preventive (PREV) administration of the probiotic with digestive enzymes supplement as compared to a control SHIME (CTRL; no supplement) from the control period (baseline microbial community prior to 5-FU/vancomycin) and treatment period with 5-FU/vancomycin. Cytokine levels of IL-6 (A) and IL-10 (B) were measured 6 h after LPS treatment on the basolateral side of the Caco2/THP-1 co-cultures after pre-treatment of the apical side for 24 h with the SHIME samples. The red dotted line corresponds to the experimental control consisting of LPS. Data are plotted as the mean ± SEM. The chart (lower panel) outlines the corresponding statistical analyses performed using two-way ANOVA with Dunnett's multiple comparisons test. Significance is depicted where (*). (*), (**), (***) and (****) represent p < 0.05, p < 0.01, p < 0.001 and p < 0.0001, respectively. Ns = non-specific; PC: proximal colon; DC: distal colon.